A new scientific statement identifies the risks and benefits of novel interventional devices compared to anticoagulation alone in the treatment of patients with pulmonary embolism. Authors conclude there is little data — particularly, as it pertains to the treatment of patients with ‘intermediate-risk PE’ — that suggests these interventional approaches are more safe and effective than the use of anticoagulation alone.